ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia. (Q51744681)
Jump to navigation
Jump to search
scientific article published on 23 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia. |
scientific article published on 23 February 2018 |
Statements
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia (English)
Cristina Mascaró
Iñigo Tirapu
Angels Estiarte
Filippo Ciceri
Serena Lunardi
Nathalie Guibourt
Alvaro Perdones
Michele M P Lufino
Cihangir Duy
Ari Melnick
Alberto Ortega
Marc Martinell
Guido Kurz
Matthew Fyfe
Julio Cesar Castro-Palomino